StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Effient (prasugrel) by Quarter

Effient (prasugrel) — Worldwide revenue ($M) [legacy separate disclosure] ($M)

QuarterlyAnnual

Eli Lilly Effient (prasugrel): $17.4M in Q4 2018, down 72.1% from a year earlier. No newer figure appears in the documents we track.

Latest, Q4 2018
17.4
Period ended Dec 31, 2018
Change on a year earlier
-72.1%
62.3 in Q4 2017
History
28 quarters
Since Q1 2010
Sources
22
Documents cited below

Where the Q4 2018 figure comes from

Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)

Source: Form 10-K (filed 2019-02-19) ↗

Reported in Form 10-Q / 10-K Note 2 & MD&A (legacy separate product disclosure prior to FY2025 reorganization).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEffient (prasugrel) — Worldwide revenue ($M) [legacy separate disclosure] ($M)Year on yearSource
Q4 2018Dec 31, 201817.4-72.1%Form 10-K (filed 2019-02-19) ↗
Q3 2018Sep 30, 201845.3-19.0%Form 10-Q (filed 2018-11-06) ↗
Q2 2018Jun 30, 201827.9-80.5%Form 10-Q (filed 2018-07-25) ↗
Q1 2018Mar 31, 201831.6-75.3%Form 10-Q (filed 2018-04-27) ↗
Q4 2017Dec 31, 201762.3–Form 10-K (filed 2019-02-19) ↗
Q3 2017Sep 30, 201755.9–Form 10-Q (filed 2018-11-06) ↗
Q2 2017Jun 30, 2017143–Form 10-Q (filed 2018-07-25) ↗
Q1 2017Mar 31, 2017128–Form 10-Q (filed 2018-04-27) ↗
Q4 2015Dec 31, 2015140+1.8%Form 10-K (filed 2016-02-19) ↗
Q3 2015Sep 30, 2015132+0.5%Form 10-Q (filed 2015-10-30) ↗
Q2 2015Jun 30, 2015129-3.6%Form 10-Q (filed 2015-07-30) ↗
Q1 2015Mar 31, 2015122+2.1%Form 10-Q (filed 2015-04-30) ↗
Q4 2014Dec 31, 2014138–Form 10-K (filed 2015-02-19) ↗
Q3 2014Sep 30, 2014132–Form 10-Q (filed 2014-10-29) ↗
Q2 2014Jun 30, 2014134-2.8%Form 10-Q (filed 2014-07-28) ↗
Q1 2014Mar 31, 2014119+2.9%Form 10-Q (filed 2014-04-28) ↗

Breakdown

What makes up effient (prasugrel)

Cite this data

StockData. (2026). Eli Lilly Effient (prasugrel) ($M), quarterly Q1 2010–Q4 2018 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-effient-ww

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.